Folding versus aggregation: Polypeptide conformations on competing pathways
暂无分享,去创建一个
[1] Lorna J. Smith,et al. Long-Range Interactions Within a Nonnative Protein , 2002, Science.
[2] Sheena E Radford,et al. Intermediates: ubiquitous species on folding energy landscapes? , 2007, Current opinion in structural biology.
[3] K. Dill,et al. From Levinthal to pathways to funnels , 1997, Nature Structural Biology.
[4] H. Rye,et al. GroEL-Mediated Protein Folding: Making the Impossible, Possible , 2006, Critical reviews in biochemistry and molecular biology.
[5] Michele Vendruscolo,et al. Determination of the folding transition states of barnase by using PhiI-value-restrained simulations validated by double mutant PhiIJ-values. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[6] Adam Douglass,et al. Mechanism of Prion Propagation: Amyloid Growth Occurs by Monomer Addition , 2004, PLoS biology.
[7] Michele Vendruscolo,et al. Structural interpretation of hydrogen exchange protection factors in proteins: characterization of the native state fluctuations of CI2. , 2006, Structure.
[8] J. Onuchic,et al. Navigating the folding routes , 1995, Science.
[9] M. Goldberg,et al. Renaturation of Escherichia coli tryptophanase after exposure to 8 M urea. Evidence for the existence of nucleation centers. , 1974, European journal of biochemistry.
[10] Louise C Serpell,et al. Structures for amyloid fibrils , 2005, The FEBS journal.
[11] D. Baker,et al. The Highly Cooperative Folding of Small Naturally Occurring Proteins Is Likely the Result of Natural Selection , 2007, Cell.
[12] L. Kay,et al. Intrinsic dynamics of an enzyme underlies catalysis , 2005, Nature.
[13] T. Sosnick,et al. Fast and slow intermediate accumulation and the initial barrier mechanism in protein folding. , 2002, Journal of molecular biology.
[14] Jonathan W. Yewdell,et al. Rapid degradation of a large fraction of newly synthesized proteins by proteasomes , 2000, Nature.
[15] Thomas Scheibel,et al. The elongation of yeast prion fibers involves separable steps of association and conversion. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[16] J. Collinge. Prion diseases of humans and animals: their causes and molecular basis. , 2001, Annual review of neuroscience.
[17] D. Boehr,et al. The Dynamic Energy Landscape of Dihydrofolate Reductase Catalysis , 2006, Science.
[18] C. Dobson,et al. Protein aggregation and amyloid fibril formation by an SH3 domain probed by limited proteolysis. , 2003, Journal of molecular biology.
[19] F. Hartl,et al. Chaperonin TRiC promotes the assembly of polyQ expansion proteins into nontoxic oligomers. , 2006, Molecular cell.
[20] K. Sletten,et al. Characterization of amyloid fibril proteins from medullary carcinoma of the thyroid , 1976, The Journal of experimental medicine.
[21] K. Crowhurst,et al. Cooperative interactions and a non-native buried Trp in the unfolded state of an SH3 domain. , 2002, Journal of molecular biology.
[22] L. Serrano,et al. A comparative study of the relationship between protein structure and beta-aggregation in globular and intrinsically disordered proteins. , 2004, Journal of molecular biology.
[23] M. Gallagher,et al. A specific amyloid-β protein assembly in the brain impairs memory , 2006, Nature.
[24] Everett A Lipman,et al. Single-Molecule Measurement of Protein Folding Kinetics , 2003, Science.
[25] Christopher M. Dobson,et al. The protofilament structure of insulin amyloid fibrils , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[26] S. Lindquist,et al. Structural insights into a yeast prion illuminate nucleation and strain diversity , 2005, Nature.
[27] J. Sipe,et al. Review: history of the amyloid fibril. , 2000, Journal of structural biology.
[28] W. P. Russ,et al. Evolutionary information for specifying a protein fold , 2005, Nature.
[29] S. Radford,et al. Amyloid under the atomic force microscope. , 2006, Protein and peptide letters.
[30] C. Dobson,et al. Evidence for a mechanism of amyloid formation involving molecular reorganisation within native-like precursor aggregates. , 2005, Journal of molecular biology.
[31] George B. Benedek,et al. Kinetic theory of fibrillogenesis of amyloid β-protein , 1997 .
[32] Amedeo Caflisch,et al. Computational models for the prediction of polypeptide aggregation propensity. , 2006, Current opinion in chemical biology.
[33] M. Sowa,et al. The ClpB/Hsp104 molecular chaperone-a protein disaggregating machine. , 2004, Journal of structural biology.
[34] J. Kelly,et al. Partitioning conformational intermediates between competing refolding and aggregation pathways: insights into transthyretin amyloid disease. , 2005, Biochemistry.
[35] W. Surewicz,et al. The Effect of Disease-associated Mutations on the Folding Pathway of Human Prion Protein* , 2004, Journal of Biological Chemistry.
[36] Fabrizio Chiti,et al. Sequence and structural determinants of amyloid fibril formation. , 2006, Accounts of chemical research.
[37] Jun-tao Guo,et al. Molecular modeling of the core of Aβ amyloid fibrils , 2004 .
[38] F. Hartl,et al. Roles of molecular chaperones in protein misfolding diseases. , 2004, Seminars in cell & developmental biology.
[39] G. Glenner,et al. X-RAY DIFFRACTION STUDIES ON AMYLOID FILAMENTS , 1968, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[40] C. Dobson,et al. Low-populated folding intermediates of Fyn SH3 characterized by relaxation dispersion NMR , 2004, Nature.
[41] D. Walsh,et al. Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate. , 1997, The Journal of biological chemistry.
[42] Kresten Lindorff-Larsen,et al. Protein folding and the organization of the protein topology universe. , 2005, Trends in biochemical sciences.
[43] R. Wetzel,et al. Polymorphism in the intermediates and products of amyloid assembly. , 2007, Current opinion in structural biology.
[44] S. Santini,et al. Pathway Complexity of Alzheimer's β-Amyloid Aβ16-22 Peptide Assembly , 2004 .
[45] K. Iwata,et al. 3D structure of amyloid protofilaments of β2-microglobulin fragment probed by solid-state NMR , 2006, Proceedings of the National Academy of Sciences.
[46] Sören Doose,et al. A microscopic view of miniprotein folding: enhanced folding efficiency through formation of an intermediate. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[47] A. Fersht,et al. Demonstration of a low-energy on-pathway intermediate in a fast-folding protein by kinetics, protein engineering, and simulation. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[48] R. Kayed,et al. Common structure and toxic function of amyloid oligomers implies a common mechanism of pathogenesis , 2006, Neurology.
[49] H. Paulson,et al. Protein aggregation and the ubiquitin proteasome pathway: gaining the UPPer hand on neurodegeneration. , 2003, Current opinion in genetics & development.
[50] Susan Lindquist,et al. Prions as adaptive conduits of memory and inheritance , 2005, Nature Reviews Genetics.
[51] S. Radford,et al. Characterisation of the conformational properties of urea-unfolded Im7: implications for the early stages of protein folding. , 2006, Journal of molecular biology.
[52] C. Redfield. NMR studies of partially folded molten-globule states. , 2004, Methods in molecular biology.
[53] D. Hoyt,et al. Deuterium-proton exchange on the native wild-type transthyretin tetramer identifies the stable core of the individual subunits and indicates mobility at the subunit interface. , 2000, Journal of molecular biology.
[54] C. Dobson,et al. Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution , 2003, Journal of Molecular Medicine.
[55] Giampaolo Merlini,et al. Amyloid: Toward terminology clarification Report from the Nomenclature Committee of the International Society of Amyloidosis , 2005, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[56] R. Nussinov,et al. Sequence and structure analysis of parallel beta helices: implication for constructing amyloid structural models. , 2006, Structure.
[57] Mehmet Sarikaya,et al. Hsp70 and Hsp40 attenuate formation of spherical and annular polyglutamine oligomers by partitioning monomer , 2004, Nature Structural &Molecular Biology.
[58] Hideyuki Okano,et al. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice , 2006, Nature.
[59] Yawen Bai. Hidden intermediates and levinthal paradox in the folding of small proteins. , 2003, Biochemical and biophysical research communications.
[60] R. Seckler,et al. Mapping protein collapse with single-molecule fluorescence and kinetic synchrotron radiation circular dichroism spectroscopy , 2006, Proceedings of the National Academy of Sciences.
[61] Richard D. Leapman,et al. Self-Propagating, Molecular-Level Polymorphism in Alzheimer's ß-Amyloid Fibrils , 2005, Science.
[62] A. Esteras-Chopo,et al. The amyloid stretch hypothesis: recruiting proteins toward the dark side. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[63] H. Saibil,et al. Structural diversity of ex vivo amyloid fibrils studied by cryo-electron microscopy. , 2001, Journal of molecular biology.
[64] G. Damaschun,et al. Assembly of amyloid protofibrils via critical oligomers--a novel pathway of amyloid formation. , 2003, Journal of molecular biology.
[65] David Eisenberg,et al. Amyloid-like fibrils of ribonuclease A with three-dimensional domain-swapped and native-like structure , 2005, Nature.
[66] Christopher M. Dobson,et al. Kinetic partitioning of protein folding and aggregation , 2002, Nature Structural Biology.
[67] P. Lansbury,et al. Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. , 1997, Annual review of biochemistry.
[68] S. Englander,et al. Protein misfolding: optional barriers, misfolded intermediates, and pathway heterogeneity. , 2004, Journal of molecular biology.
[69] R. Riek,et al. 3D structure of Alzheimer's amyloid-β(1–42) fibrils , 2005 .
[70] Masaaki Komatsu,et al. Loss of autophagy in the central nervous system causes neurodegeneration in mice , 2006, Nature.
[71] S. Radford,et al. NMR Analysis of the Conformational Properties of the Trapped on-pathway Folding Intermediate of the Bacterial Immunity Protein Im7 , 2007, Journal of molecular biology.
[72] B. Schuler. Single-molecule fluorescence spectroscopy of protein folding. , 2005, Chemphyschem : a European journal of chemical physics and physical chemistry.
[73] S. Teichmann,et al. The folding and evolution of multidomain proteins , 2007, Nature Reviews Molecular Cell Biology.
[74] J. Kelly,et al. Sequence-dependent denaturation energetics: A major determinant in amyloid disease diversity , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[75] Jonathan S. Weissman,et al. The physical basis of how prion conformations determine strain phenotypes , 2006, Nature.
[76] John Q Trojanowski,et al. Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs , 2004, Nature Medicine.
[77] S. Teichmann,et al. The importance of sequence diversity in the aggregation and evolution of proteins , 2005, Nature.
[78] S. Radford,et al. Dynamics in the unfolded state of beta2-microglobulin studied by NMR. , 2005, Journal of molecular biology.
[79] H. Roder,et al. Early kinetic intermediate in the folding of acyl-CoA binding protein detected by fluorescence labeling and ultrarapid mixing , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[80] R. Wetzel. Ideas of order for amyloid fibril structure. , 2002, Structure.
[81] Michele Vendruscolo,et al. Prediction of the absolute aggregation rates of amyloidogenic polypeptide chains. , 2004, Journal of molecular biology.
[82] S. Radford,et al. Partially unfolded states of beta(2)-microglobulin and amyloid formation in vitro. , 2000, Biochemistry.
[83] D. Raleigh,et al. The unfolded state of NTL9 is compact in the absence of denaturant. , 2006, Biochemistry.
[84] E. Kandel,et al. A Neuronal Isoform of the Aplysia CPEB Has Prion-Like Properties , 2003, Cell.
[85] Yawen Bai,et al. A protein folding pathway with multiple folding intermediates at atomic resolution. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[86] Heather T. McFarlane,et al. Atomic structures of amyloid cross-β spines reveal varied steric zippers , 2007, Nature.
[87] S. Radford,et al. Competing pathways determine fibril morphology in the self-assembly of beta2-microglobulin into amyloid. , 2005, Journal of molecular biology.
[88] L. Kay,et al. NMR studies of protein structure and dynamics. , 2005, Journal of magnetic resonance.
[89] Louise C. Serpell,et al. Synchrotron X-ray studies suggest that the core of the transthyretin amyloid fibril is a continuous β-sheet helix , 1996 .
[90] Elena Orlova,et al. Cryo‐electron microscopy structure of an SH3 amyloid fibril and model of the molecular packing , 1999, The EMBO journal.
[91] K. Kuwajima,et al. Role of the molten globule state in protein folding. , 2000, Advances in protein chemistry.
[92] A. Caflisch,et al. The role of side-chain interactions in the early steps of aggregation: Molecular dynamics simulations of an amyloid-forming peptide from the yeast prion Sup35 , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[93] Yawen Bai. Energy barriers, cooperativity, and hidden intermediates in the folding of small proteins. , 2006, Biochemical and biophysical research communications.
[94] Min Goo Lee,et al. A protein sequence that can encode native structure by disfavoring alternate conformations , 2002, Nature Structural Biology.
[95] Ying Xu,et al. Mapping abeta amyloid fibril secondary structure using scanning proline mutagenesis. , 2004, Journal of molecular biology.
[96] K. Lindorff-Larsen,et al. Characterization of the residual structure in the unfolded state of the Δ131Δ fragment of staphylococcal nuclease , 2006 .
[97] S. Marqusee,et al. The kinetic folding intermediate of ribonuclease H resembles the acid molten globule and partially unfolded molecules detected under native conditions , 1997, Nature Structural Biology.
[98] R. Leapman,et al. A structural model for Alzheimer's β-amyloid fibrils based on experimental constraints from solid state NMR , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[99] F. Ding,et al. Scaling behavior and structure of denatured proteins. , 2005, Structure.
[100] Ruth Nussinov,et al. Simulations as analytical tools to understand protein aggregation and predict amyloid conformation. , 2006, Current opinion in chemical biology.
[101] J. Collinge,et al. Elongated oligomers assemble into mammalian PrP amyloid fibrils. , 2006, Journal of molecular biology.
[102] A. Fersht,et al. Phi-value analysis and the nature of protein-folding transition states. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[103] P E Wright,et al. Formation of a molten globule intermediate early in the kinetic folding pathway of apomyoglobin. , 1993, Science.
[104] C. Matthews,et al. Molecular dimensions and their distributions in early folding intermediates. , 2006, Current opinion in structural biology.
[105] Daniel I. C. Wang,et al. Specific aggregation of partially folded polypeptide chains: The molecular basis of inclusion body composition , 1996, Nature Biotechnology.
[106] H. Roder,et al. Early events in protein folding explored by rapid mixing methods. , 2006, Chemical reviews.
[107] P. Carey,et al. Proinsulin Is Refractory to Protein Fibrillation , 2005, Journal of Biological Chemistry.
[108] Daniel J. Klionsky,et al. Autophagy in Health and Disease: A Double-Edged Sword , 2004, Science.
[109] C. Hall,et al. Molecular dynamics simulations of spontaneous fibril formation by random-coil peptides. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[110] J. Udgaonkar,et al. Characterization of the formation of amyloid protofibrils from barstar by mapping residue-specific fluorescence dynamics. , 2006, Journal of molecular biology.
[111] J. Kelly,et al. Partial denaturation of transthyretin is sufficient for amyloid fibril formation in vitro. , 1992, Biochemistry.
[112] C. Dobson,et al. Rationalization of the effects of mutations on peptide andprotein aggregation rates , 2003, Nature.
[113] D. Kern,et al. The role of dynamics in allosteric regulation. , 2003, Current opinion in structural biology.
[114] J. Kelly,et al. Amyloid as a natural product , 2003, The Journal of cell biology.
[115] S. Radford,et al. Determination of an ensemble of structures representing the intermediate state of the bacterial immunity protein Im7. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[116] C. V. van Mierlo,et al. The folding energy landscape of apoflavodoxin is rugged: hydrogen exchange reveals nonproductive misfolded intermediates. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[117] Ehud Cohen,et al. Opposing Activities Protect Against Age-Onset Proteotoxicity , 2006, Science.
[118] T. Ohkuri,et al. Amyloid formation in denatured single‐mutant lysozymes where residual structures are modulated , 2006, Protein science : a publication of the Protein Society.
[119] T. Yeates,et al. Arrangement of subunits and ordering of β-strands in an amyloid sheet , 2002, Nature Structural Biology.
[120] M. Oliveberg. Characterisation of the transition states for protein folding: towards a new level of mechanistic detail in protein engineering analysis. , 2001, Current opinion in structural biology.
[121] M. Tuite,et al. Propagation of yeast prions , 2003, Nature Reviews Molecular Cell Biology.
[122] S. Radford,et al. Direct observation of oligomeric species formed in the early stages of amyloid fibril formation using electrospray ionisation mass spectrometry. , 2006, Journal of molecular biology.
[123] T. Kiefhaber,et al. End-to-end distance distributions and intrachain diffusion constants in unfolded polypeptide chains indicate intramolecular hydrogen bond formation , 2006, Proceedings of the National Academy of Sciences.
[124] A. Andreotti,et al. Native state proline isomerization: an intrinsic molecular switch. , 2003, Biochemistry.
[125] D. Selkoe,et al. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide , 2007, Nature Reviews Molecular Cell Biology.
[126] M. Karplus,et al. Structures and relative free energies of partially folded states of proteins , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[127] S. Radford,et al. Structural properties of an amyloid precursor of β2-microglobulin , 2002, Nature Structural Biology.
[128] Shuguang Zhang. Fabrication of novel biomaterials through molecular self-assembly , 2003, Nature Biotechnology.
[129] D. Raleigh,et al. Effect of modulating unfolded state structure on the folding kinetics of the villin headpiece subdomain. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[130] R. Nussinov,et al. Folding funnels, binding funnels, and protein function , 1999, Protein science : a publication of the Protein Society.
[131] J. Markley,et al. NMR characterizations of an amyloidogenic conformational ensemble of the PI3K SH3 domain , 2006, Protein science : a publication of the Protein Society.
[132] T. Kiefhaber,et al. Evidence for sequential barriers and obligatory intermediates in apparent two-state protein folding. , 2003, Journal of molecular biology.
[133] I D Campbell,et al. Amyloid fibril formation by an SH3 domain. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[134] L. Serrano,et al. Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins , 2004, Nature Biotechnology.
[135] M. Hecht,et al. Nature disfavors sequences of alternating polar and non-polar amino acids: implications for amyloidogenesis. , 2000, Journal of molecular biology.
[136] Yawen Bai,et al. The folding pathway of T4 lysozyme: the high-resolution structure and folding of a hidden intermediate. , 2007, Journal of molecular biology.
[137] F. Cohen,et al. Pathway Complexity of Prion Protein Assembly into Amyloid* , 2002, The Journal of Biological Chemistry.
[138] David Eisenberg,et al. Runaway domain swapping in amyloid-like fibrils of T7 endonuclease I. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[139] Sheena E. Radford,et al. Ultrarapid mixing experiments reveal that Im7 folds via an on-pathway intermediate , 2001, Nature Structural Biology.
[140] O. Bocharova,et al. Amyloid Fibrils of Mammalian Prion Protein Are Highly Toxic to Cultured Cells and Primary Neurons* , 2006, Journal of Biological Chemistry.
[141] H. True,et al. A yeast prion provides a mechanism for genetic variation and phenotypic diversity , 2000, Nature.
[142] M. R. Nilsson. Techniques to study amyloid fibril formation in vitro. , 2004, Methods.
[143] D. Raleigh,et al. Characterizing a partially folded intermediate of the villin headpiece domain under non-denaturing conditions: contribution of His41 to the pH-dependent stability of the N-terminal subdomain. , 2006, Journal of molecular biology.
[144] S. Radford,et al. Trapping the on-pathway folding intermediate of Im7 at equilibrium. , 2004, Journal of molecular biology.
[145] G. Westermark,et al. Aberrant processing of human proislet amyloid polypeptide results in increased amyloid formation. , 2005, Diabetes.
[146] G. Merlini,et al. Lysozyme: a paradigmatic molecule for the investigation of protein structure, function and misfolding. , 2005, Clinica chimica acta; international journal of clinical chemistry.
[147] A. Esteras-Chopo,et al. Early kinetics of amyloid fibril formation reveals conformational reorganisation of initial aggregates. , 2007, Journal of molecular biology.
[148] S. Radford,et al. Investigating the structural properties of amyloid-like fibrils formed in vitro from beta2-microglobulin using limited proteolysis and electrospray ionisation mass spectrometry. , 2006, Rapid communications in mass spectrometry : RCM.
[149] Peter Chien,et al. Emerging principles of conformation-based prion inheritance. , 2004, Annual review of biochemistry.
[150] Michele Vendruscolo,et al. Theoretical approaches to protein aggregation. , 2006, Protein and peptide letters.
[151] J. Klein-Seetharaman,et al. Modulation of compactness and long-range interactions of unfolded lysozyme by single point mutations. , 2004, Angewandte Chemie.
[152] P. Lansbury,et al. Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. , 2003, Annual review of neuroscience.
[153] C. Dobson,et al. Glycine residues appear to be evolutionarily conserved for their ability to inhibit aggregation. , 2005, Structure.
[154] Atanas V Koulov,et al. Functional Amyloid Formation within Mammalian Tissue , 2005, PLoS biology.
[155] D. Selkoe,et al. Oligomers on the brain: the emerging role of soluble protein aggregates in neurodegeneration. , 2004, Protein and peptide letters.
[156] I. E. Sánchez,et al. Formation of on- and off-pathway intermediates in the folding kinetics of Azotobacter vinelandii apoflavodoxin. , 2004, Biochemistry.
[157] Christopher M. Dobson,et al. A camelid antibody fragment inhibits the formation of amyloid fibrils by human lysozyme , 2003, Nature.
[158] A. R. Fersht,et al. Solution structure of a protein denatured state and folding intermediate , 2005, Nature.
[159] A. Fink,et al. Characterization of oligomers during alpha-synuclein aggregation using intrinsic tryptophan fluorescence. , 2006, Biochemistry.
[160] M. J. Parker,et al. Amyloid formation under physiological conditions proceeds via a native-like folding intermediate , 2006, Nature Structural &Molecular Biology.
[161] P. Satpute-Krishnan,et al. Prion protein remodelling confers an immediate phenotypic switch , 2005, Nature.
[162] A. Zarrine-Afsar,et al. The family feud: do proteins with similar structures fold via the same pathway? , 2005, Current opinion in structural biology.
[163] A. Fink. Natively unfolded proteins. , 2005, Current opinion in structural biology.
[164] David Eisenberg,et al. Recent atomic models of amyloid fibril structure. , 2006, Current opinion in structural biology.
[165] C. Dobson,et al. Protein misfolding, functional amyloid, and human disease. , 2006, Annual review of biochemistry.
[166] A. Fersht,et al. Folding of chymotrypsin inhibitor 2. 1. Evidence for a two-state transition. , 1991, Biochemistry.
[167] David Eisenberg,et al. A domain-swapped RNase A dimer with implications for amyloid formation , 2001, Nature Structural Biology.
[168] Robert A. Grothe,et al. Structure of the cross-β spine of amyloid-like fibrils , 2005, Nature.
[169] M. Karplus,et al. Three key residues form a critical contact network in a protein folding transition state , 2001, Nature.
[170] Robert L. Baldwin,et al. Refolding and unfolding kinetics of the equilibrium folding intermediate of apomyoglobin , 1996, Nature Structural Biology.
[171] Sheena E Radford,et al. The Yin and Yang of protein folding , 2005, The FEBS journal.
[172] J. Richardson,et al. Natural β-sheet proteins use negative design to avoid edge-to-edge aggregation , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[173] I. Bahar,et al. Structural changes involved in protein binding correlate with intrinsic motions of proteins in the unbound state. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[174] S. Marqusee,et al. Native state energetics of the Src SH2 domain: Evidence for a partially structured state in the denatured ensemble , 2006, Protein science : a publication of the Protein Society.
[175] K. Plaxco,et al. Is There or Isn't There? The Case for (and Against) Residual Structure in Chemically Denatured Proteins , 2005, Critical reviews in biochemistry and molecular biology.
[176] J. Sipe. Amyloid proteins : the beta sheet conformation and disease , 2005 .
[177] S. Radford,et al. Urea-induced unfolding of the immunity protein Im9 monitored by spFRET. , 2006, Biophysical journal.
[178] Gerd Krause,et al. General structural motifs of amyloid protofilaments , 2006, Proceedings of the National Academy of Sciences.
[179] A. Fink,et al. Characterization of Oligomeric Intermediates in α-Synuclein Fibrillation: FRET Studies of Y125W/Y133F/Y136F α-Synuclein , 2005 .
[180] M. Oliveberg,et al. Malleability of protein folding pathways: a simple reason for complex behaviour. , 2007, Current opinion in structural biology.
[181] Amedeo Caflisch,et al. Organism complexity anti‐correlates with proteomic β‐aggregation propensity , 2005, Protein science : a publication of the Protein Society.
[182] M. J. Conroy,et al. Three‐dimensional domain swapping in the folded and molten‐globule states of cystatins, an amyloid‐forming structural superfamily , 2001, The EMBO journal.
[183] P. Hammarström,et al. Is the unfolded state the Rosetta Stone of the protein folding problem? , 2000, Biochemical and biophysical research communications.
[184] R. Kayed,et al. Small Molecule Inhibitors of Aggregation Indicate That Amyloid β Oligomerization and Fibrillization Pathways Are Independent and Distinct* , 2007, Journal of Biological Chemistry.
[185] P. Muchowski. Protein Misfolding, Amyloid Formation, and Neurodegeneration A Critical Role for Molecular Chaperones? , 2002, Neuron.
[186] C. Dobson,et al. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases , 2002, Nature.
[187] Michele Vendruscolo,et al. Towards complete descriptions of the free–energy landscapes of proteins , 2005, Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences.
[188] A. Alexandrescu. Amyloid accomplices and enforcers , 2005, Protein science : a publication of the Protein Society.
[189] Ruth Nussinov,et al. Peptide sequence and amyloid formation; molecular simulations and experimental study of a human islet amyloid polypeptide fragment and its analogs. , 2004, Structure.
[190] Roger Cooke,et al. Conformational variations in an infectious protein determine prion strain differences , 2004, Nature.
[191] P. Wesseling,et al. Heparan sulphate proteoglycans in Alzheimer's disease and amyloid‐related disorders , 2003, The Lancet Neurology.
[192] A. Miranker,et al. A native to amyloidogenic transition regulated by a backbone trigger , 2006, Nature Structural &Molecular Biology.
[193] A. Fersht,et al. Protein Folding and Unfolding at Atomic Resolution , 2002, Cell.
[194] R. Wetzel. Kinetics and thermodynamics of amyloid fibril assembly. , 2006, Accounts of chemical research.
[195] J. Weissman,et al. Mechanism of Cross-Species Prion Transmission An Infectious Conformation Compatible withTwo Highly Divergent Yeast Prion Proteins , 2005, Cell.
[196] A. Fersht,et al. Mapping the transition state and pathway of protein folding by protein engineering , 1989, Nature.
[197] Frederic Rousseau,et al. How evolutionary pressure against protein aggregation shaped chaperone specificity. , 2006, Journal of molecular biology.
[198] H. Dyson,et al. Identification of native and non-native structure in kinetic folding intermediates of apomyoglobin. , 2006, Journal of molecular biology.
[199] Thorsten Lührs,et al. Correlation of structural elements and infectivity of the HET-s prion , 2005, Nature.
[200] Christopher M. Dobson,et al. Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis , 1997, Nature.
[201] Sean R. Collins,et al. Generation of prion transmission barriers by mutational control of amyloid conformations , 2003, Nature.
[202] Patricia L Clark,et al. Protein folding in the cell: reshaping the folding funnel. , 2004, Trends in biochemical sciences.
[203] Michele Vendruscolo,et al. Determination of conformationally heterogeneous states of proteins. , 2007, Current opinion in structural biology.
[204] C M Dobson,et al. Designing conditions for in vitro formation of amyloid protofilaments and fibrils. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[205] J T Finch,et al. Amyloid fibers are water-filled nanotubes , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[206] Lorna J. Smith,et al. Understanding protein folding via free-energy surfaces from theory and experiment. , 2000, Trends in biochemical sciences.
[207] J. Clarke,et al. Sequence conservation in Ig-like domains: the role of highly conserved proline residues in the fibronectin type III superfamily. , 2002, Journal of molecular biology.
[208] C. Matthews,et al. Sequential vs. parallel protein-folding mechanisms: experimental tests for complex folding reactions. , 2002, Biophysical chemistry.
[209] J. Forman-Kay,et al. Atomic-level characterization of disordered protein ensembles. , 2007, Current opinion in structural biology.
[210] Alan R Davidson,et al. The analysis of protein folding kinetic data produced in protein engineering experiments. , 2004, Methods.
[211] V. Uversky,et al. Evidence for a Partially Folded Intermediate in α-Synuclein Fibril Formation* , 2001, The Journal of Biological Chemistry.
[212] N. Heintz,et al. Autophagy and Its Possible Roles in Nervous System Diseases, Damage and Repair , 2005, Autophagy.
[213] Mireille Dumoulin,et al. Reduced global cooperativity is a common feature underlying the amyloidogenicity of pathogenic lysozyme mutations. , 2005, Journal of molecular biology.
[214] M. Oliveberg,et al. Folding of Cu/Zn superoxide dismutase suggests structural hotspots for gain of neurotoxic function in ALS: Parallels to precursors in amyloid disease , 2006, Proceedings of the National Academy of Sciences.
[215] S. Englander,et al. Hydrogen exchange methods to study protein folding. , 2004, Methods.
[216] F. Hartl,et al. Molecular Chaperones in the Cytosol: from Nascent Chain to Folded Protein , 2002, Science.
[217] J. Kemp,et al. Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis , 2002, Nature.
[218] C. Matthews,et al. A tightly packed hydrophobic cluster directs the formation of an off-pathway sub-millisecond folding intermediate in the alpha subunit of tryptophan synthase, a TIM barrel protein. , 2007, Journal of molecular biology.
[219] R. Wetzel,et al. Structural differences in Abeta amyloid protofibrils and fibrils mapped by hydrogen exchange--mass spectrometry with on-line proteolytic fragmentation. , 2006, Journal of molecular biology.
[220] S. Radford,et al. Hierarchical Assembly of β2-Microglobulin Amyloid In Vitro Revealed by Atomic Force Microscopy , 2003 .
[221] V. Uversky,et al. Conformational constraints for amyloid fibrillation: the importance of being unfolded. , 2004, Biochimica et biophysica acta.
[222] M. Stefani. Protein misfolding and aggregation: new examples in medicine and biology of the dark side of the protein world. , 2004, Biochimica et biophysica acta.
[223] John I. Clark,et al. Small heat-shock proteins and their potential role in human disease. , 2000, Current opinion in structural biology.